NCT05671081View on ClinicalTrials.gov

Dexmedetomidine Versus Magnesium Sulfate in Ultrasound Guided Bilateral Bi-level Erector Spinae Plane Block in Corrective Scoliosis Surgery

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 5, 2023

Primary Completion Date

March 15, 2024

Study Completion Date

March 15, 2024

Conditions
Anesthesia , Analgesia
Interventions
DRUG

Dexmedetomidine

patients will receive combined general anesthesia and bilateral bilevel at T5 \&T10 Erector spinae plane block with 20mL of bupivacaine 0.125 %. plus 0.5 μg/kgof Dexmedetomidine for each injection

DRUG

Magnesium sulfate

patients will receive combined general anesthesia and bilateral bilevel at T5 \&T10 Erector spinae plane block with 20mL of bupivacaine 0.125 %. plus 2 mg/kg Magnesium sulfate for each injection

DRUG

Narcotic Analgesics

patients will receive general anesthesia and conventional intraoperative and postoperative analgesia

Trial Locations (1)

Unknown

Ain Shams University hospitals, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER